Join Michael Hochman, MD, MPH, for the second episode of Updates in Slow Medicine. This installment discusses results from a recent study that raises the possibility that a…
NEW YORK (Reuters Health) – A fibrin-derived peptide (FX06) appears to limit infarct size when given during percutaneous coronary intervention (PCI) for acute ST-segment elevation myocardial infarction, according…
DMC pediatric heart specialist uses less invasive technique to repair a child’s Atrial Septal Defect (“hole in the heart”). For more information, please see: Dan Turner, M.D. Sponsored…
NEW YORK (Reuters Health) – Manual thrombus aspiration during primary percutaneous coronary intervention (PCI) improves myocardial reperfusion and reduces final infarct size in patients with ST-segment elevation myocardial…
NEW YORK (Reuters Health) – Adding fractional flow reserve (FFR) measurements to angiography may improve survival and other outcomes for patients with multivessel coronary artery disease who undergo…
This minimally invasive procedure for the replacement of a defective aortic valve has many advantages over traditional open heart surgery. ~ Detroit Medical Center For more information on…
NEW YORK (Reuters Health) – Using a transradial rather than a transfemoral approach for percutaneous coronary intervention (PCI) can reduce vascular access complications and shorten the hospital stay,…
NEW YORK (Reuters Health) – Alcohol septal ablation, an increasingly popular non-surgical treatment for obstructive hypertrophic cardiomyopathy (HCM), does not appear to induce ventricular arrhythmias, new research suggests.…
NEW YORK (Reuters Health) – In patients with symptomatic hypertrophic obstructive cardiomyopathy, alcohol septal ablation results in sustained clinical and hemodynamic improvement, according to a prospective study spanning…
NEW YORK (Reuters Health) – As initial therapy in patients with low-risk, stable coronary artery disease, percutaneous coronary intervention (PCI) added to medical therapy is more effective than…
NEW YORK (Reuters Health) – Randomized trials have shown a survival benefit to using drug-eluting stents (DES) rather than bare-metal stents (BMS) in heart disease patients. Now, the…
